The pharma industry has started realizing the potential of collaborating with technology and is presently dominated by some the top spenders on pharmaceutical R&D from the U.S. This includes ace companies such as Pfizer, Merk, Bristol-Myers Squibb, Celgene corp etc., each of them investing billions of dollars every quarter. On similar lines, because of the availability of sophisticated technology and…